用单克隆抗载脂蛋白(a)抗体为包被抗体,酶标抗纤维蛋白溶酶原(Pg)抗体为检测抗体建立了人血清脂蛋白(a)[Lp(a)]中Pg位点的酶联免疫吸附试验法.方法特异,测定范围为28~880 mg/L,变异系数批内为4%~6%,批间为7%~9%.检测了正常人、冠心病(CHD)和肾衰血透患者(CRF)血清Lp(a)、Lp(a)中Pg位点和Pg/Lp(a)比值.结果示正常人血清Lp(a)水平分别同Pg、Pg/Lp(a)呈正、负相关.CHD和CRF患者Lp(a)、Pg位点和Pg/Lp(a)比值明显高于正常人,认为Lp(a)中Pg位点测定对于动脉粥样硬化的病理生理研究具有特殊的价值.
The epitopes of plasminogen (Pg) of serum lipoprotein(a)[Lp(a)][Lp(a)-Pg] were determinated by ELISA using monoclonal anti-apo(a) as the capture antibody and quantitating with anti-Pg enzyme conjugate. The assay range by this method was from 28 to 880 mg/L. The mean intra- and inter-assay coefficients of variation were 4%~6% and 7%~9%, respectively. The serum Lp(a) concentration was positively correlated with serum Lp(a)-Pg level and negatively with Lp(a)-Pg level to total Lp(a) [Lp(a)-Pg/Lp(a)] ratio. Serum Lp(a) concentration, Lp(a)-Pg level and Lp(a)-Pg/Lp(a) ratio were found significantly elevated in CHD and CRF patients compared with those in the controls. Determination of Lp(a)-Pg level and Lp(a)-Pg/Lp(a) ratio in patients with high incidence of atherosclerosis have special value.
汪俊军,庄一义.人血清脂蛋白(a)中纤维蛋白溶酶原位点测定[J].生物化学与生物物理进展,1998,25(2):170-174
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号